OBJECTIVE: Several mediators of inflammation are associated with atherosclerotic cardiovascular disease in the general population, but their relationship to accelerated atherosclerosis associated with an inflammatory disease such as systemic lupus erythematosus (SLE) is not known. METHODS: We compared concentrations of cytokines (TNF-alpha, IL-1alpha, and VEGF), inflammatory enzymes (MPO and MMP-9), acute-phase reactants (ESR, CRP, and SAA) and adhesion molecules (VCAM, ICAM, and E-selectin) in 109 patients with SLE and 78 controls. The relationship between inflammatory markers and coronary atherosclerosis detected as calcified plaque by electron beam CT was determined in patients with SLE. RESULTS: Concentrations of all markers of inflammation other than VCAM, MMP-9, and IL-1alpha were significantly higher in SLE. In multivariable analyses adjusting for Framingham risk score, cumulative corticosteroid dose, and diabetes, E-selectin (OR 1.90, 95% CI 1.08-3.33), VCAM (OR 1.99, 1.18-3.37), ICAM (OR 2.30, 1.13-4.7), and TNF-alpha (OR 2.36, 1.10-5.06) were significantly associated with the severity of coronary calcium. CONCLUSION: Concentrations of adhesion molecules and TNF-alpha are associated with coronary atherosclerosis in SLE independent of the Framingham risk score.
OBJECTIVE: Several mediators of inflammation are associated with atherosclerotic cardiovascular disease in the general population, but their relationship to accelerated atherosclerosis associated with an inflammatory disease such as systemic lupus erythematosus (SLE) is not known. METHODS: We compared concentrations of cytokines (TNF-alpha, IL-1alpha, and VEGF), inflammatory enzymes (MPO and MMP-9), acute-phase reactants (ESR, CRP, and SAA) and adhesion molecules (VCAM, ICAM, and E-selectin) in 109 patients with SLE and 78 controls. The relationship between inflammatory markers and coronary atherosclerosis detected as calcified plaque by electron beam CT was determined in patients with SLE. RESULTS: Concentrations of all markers of inflammation other than VCAM, MMP-9, and IL-1alpha were significantly higher in SLE. In multivariable analyses adjusting for Framingham risk score, cumulative corticosteroid dose, and diabetes, E-selectin (OR 1.90, 95% CI 1.08-3.33), VCAM (OR 1.99, 1.18-3.37), ICAM (OR 2.30, 1.13-4.7), and TNF-alpha (OR 2.36, 1.10-5.06) were significantly associated with the severity of coronary calcium. CONCLUSION: Concentrations of adhesion molecules and TNF-alpha are associated with coronary atherosclerosis in SLE independent of the Framingham risk score.
Authors: J M Esdaile; M Abrahamowicz; T Grodzicky; Y Li; C Panaritis; R du Berger; R Côte; S A Grover; P R Fortin; A E Clarke; J L Senécal Journal: Arthritis Rheum Date: 2001-10
Authors: T Skoog; W Dichtl; S Boquist; C Skoglund-Andersson; F Karpe; R Tang; M G Bond; U de Faire; J Nilsson; P Eriksson; A Hamsten Journal: Eur Heart J Date: 2002-03 Impact factor: 29.983
Authors: R Zhang; M L Brennan; X Fu; R J Aviles; G L Pearce; M S Penn; E J Topol; D L Sprecher; S L Hazen Journal: JAMA Date: 2001-11-07 Impact factor: 56.272
Authors: Mary J Roman; Beth-Ann Shanker; Adrienne Davis; Michael D Lockshin; Lisa Sammaritano; Ronit Simantov; Mary K Crow; Joseph E Schwartz; Stephen A Paget; Richard B Devereux; Jane E Salmon Journal: N Engl J Med Date: 2003-12-18 Impact factor: 91.245
Authors: Yu Asanuma; Annette Oeser; Ayumi K Shintani; Elizabeth Turner; Nancy Olsen; Sergio Fazio; MacRae F Linton; Paolo Raggi; C Michael Stein Journal: N Engl J Med Date: 2003-12-18 Impact factor: 91.245
Authors: K Manger; M Kusus; C Forster; D Ropers; W G Daniel; J R Kalden; S Achenbach; B Manger Journal: Ann Rheum Dis Date: 2003-09 Impact factor: 19.103
Authors: A Doria; Y Shoenfeld; R Wu; P F Gambari; M Puato; A Ghirardello; B Gilburd; S Corbanese; M Patnaik; S Zampieri; J B Peter; E Favaretto; L Iaccarino; Y Sherer; S Todesco; P Pauletto Journal: Ann Rheum Dis Date: 2003-11 Impact factor: 19.103
Authors: R Lertnawapan; A Bian; Y H Rho; P Raggi; A Oeser; J F Solus; T Gebretsadik; A Shintani; C M Stein Journal: Lupus Date: 2011-11-09 Impact factor: 2.911
Authors: Vivian K Kawai; Ingrid Avalos; Annette Oeser; John A Oates; Ginger L Milne; Joseph F Solus; Cecilia P Chung; C Michael Stein Journal: Arthritis Care Res (Hoboken) Date: 2014-02 Impact factor: 4.794
Authors: Young Hee Rho; Joseph Solus; Paolo Raggi; Annette Oeser; Tebeb Gebretsadik; Ayumi Shintani; C Michael Stein Journal: Arthritis Care Res (Hoboken) Date: 2011-04 Impact factor: 4.794
Authors: M J Ormseth; L L Swift; S Fazio; M F Linton; P Raggi; J F Solus; A Oeser; A Bian; T Gebretsadik; A Shintani; C M Stein Journal: Lupus Date: 2012-10-11 Impact factor: 2.911
Authors: Jennifer M P Woo; Zhuofeng Lin; Mohamad Navab; Casey Van Dyck; Yvette Trejo-Lopez; Krystal M T Woo; Hongyun Li; Lawrence W Castellani; Xuping Wang; Noriko Iikuni; Ornella J Rullo; Hui Wu; Antonio La Cava; Alan M Fogelman; Aldons J Lusis; Betty P Tsao Journal: Arthritis Res Ther Date: 2010-05-18 Impact factor: 5.156